GlassScriptPhysician profile
Gerard A Leotaud
NPI 1790936029
$3,569.16
in general payments reported to CMS, 2019-2025
14 companies · $319 in 2025
The $319 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,263 · 2020: $279 · 2021: $632 · 2022: $183 · 2023: $440 · 2024: $454 · 2025: $319.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,213.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,213.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Wright Medical Technology, INC. | $1,009.70 | 2019-2020 | |
| Stryker Corporation | $933.02 | 2021-2025 | Citrefix, Easyfuse, Prostep Mica |
| Smith+Nephew, INC. | $625.21 | 2019-2022 | |
| Treace Medical Concepts, INC. | $323.72 | 2021-2023 | |
| Abbott Laboratories | $194.45 | 2021 | |
| Integra Lifesciences Corporation | $152.08 | 2023 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Ets Wound Care LLC | $117.22 | 2024 | Mirragen Advanced Wound Matrix |
| Averitas Pharma INC. | $91.05 | 2024 | Qutenza |
| Ironwood Pharmaceuticals, INC | $29.79 | 2024 | |
| Musculoskeletal Transplant Foundation INC. | $29.21 | 2024 | |
| Ossio INC | $21.35 | 2023 | |
| Kerecis Limited | $17.36 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $13.64 | 2019 | |
| Orthofix Medical, INC. | $11.36 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gerard Leotaud listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.